Testing of saliva and serum for HIV in high-risk populations

M. Vall Mayans; J. Casabona; N. Rabella; D. De Miniac; A. Rodés; A. Marco; J. Trabal; C. Trilla

doi:10.1007/BF01690881

Testing of saliva and serum for HIV in high-risk populations

M. Vall Mayans, J. Casabona, N. Rabella, D. De Miniac, A. Rodés, A. Marco, J. Trabal, C. Trilla

Research output: Contribution to journal › Article › Research › peer-review

13 Citations (Scopus)

Abstract

Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.

Original language	English
Pages (from-to)	710-713
Journal	European Journal of Clinical Microbiology and Infectious Diseases
Volume	14
DOIs	https://doi.org/10.1007/BF01690881
Publication status	Published - 1 Aug 1995

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF01690881

Cite this

@article{fb82225189284e0daac62818141dda4b,

title = "Testing of saliva and serum for HIV in high-risk populations",

abstract = "Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. {\textcopyright} 1995 Springer-Verlag.",

author = "Mayans, {M. Vall} and J. Casabona and N. Rabella and {De Miniac}, D. and A. Rod{\'e}s and A. Marco and J. Trabal and C. Trilla",

year = "1995",

month = aug,

day = "1",

doi = "10.1007/BF01690881",

language = "English",

volume = "14",

pages = "710--713",

}

TY - JOUR

T1 - Testing of saliva and serum for HIV in high-risk populations

AU - Mayans, M. Vall

AU - Casabona, J.

AU - Rabella, N.

AU - De Miniac, D.

AU - Rodés, A.

AU - Marco, A.

AU - Trabal, J.

AU - Trilla, C.

PY - 1995/8/1

Y1 - 1995/8/1

N2 - Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.

AB - Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7-100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing. © 1995 Springer-Verlag.

U2 - 10.1007/BF01690881

DO - 10.1007/BF01690881

M3 - Article

SN - 0934-9723

VL - 14

SP - 710

EP - 713

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

ER -

Testing of saliva and serum for HIV in high-risk populations

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this